167 related articles for article (PubMed ID: 20809760)
1. The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications.
Krisht KM; Whitehead KJ; Niazi T; Couldwell WT
Neurosurg Focus; 2010 Sep; 29(3):E2. PubMed ID: 20809760
[TBL] [Abstract][Full Text] [Related]
2. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
3. Cerebral cavernous malformations arise independent of the heart of glass receptor.
Zheng X; Riant F; Bergametti F; Myers CD; Tang AT; Kleaveland B; Pan W; Yang J; Tournier-Lasserve E; Kahn ML
Stroke; 2014 May; 45(5):1505-1509. PubMed ID: 24643410
[TBL] [Abstract][Full Text] [Related]
4. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.
Akers AL; Johnson E; Steinberg GK; Zabramski JM; Marchuk DA
Hum Mol Genet; 2009 Mar; 18(5):919-30. PubMed ID: 19088123
[TBL] [Abstract][Full Text] [Related]
5. Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients.
D'Angelo R; Alafaci C; Scimone C; Ruggeri A; Salpietro FM; Bramanti P; Tomasello F; Sidoti A
Biomed Res Int; 2013; 2013():459253. PubMed ID: 24058906
[TBL] [Abstract][Full Text] [Related]
6. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
McDonald DA; Shi C; Shenkar R; Gallione CJ; Akers AL; Li S; De Castro N; Berg MJ; Corcoran DL; Awad IA; Marchuk DA
Hum Mol Genet; 2014 Aug; 23(16):4357-70. PubMed ID: 24698976
[TBL] [Abstract][Full Text] [Related]
7. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
8. Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.
Chan AC; Li DY; Berg MJ; Whitehead KJ
FEBS J; 2010 Mar; 277(5):1076-83. PubMed ID: 20096037
[TBL] [Abstract][Full Text] [Related]
9. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
Pagenstecher A; Stahl S; Sure U; Felbor U
Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
[TBL] [Abstract][Full Text] [Related]
10. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
11. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.
Fischer A; Zalvide J; Faurobert E; Albiges-Rizo C; Tournier-Lasserve E
Trends Mol Med; 2013 May; 19(5):302-8. PubMed ID: 23506982
[TBL] [Abstract][Full Text] [Related]
12. High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.
Rath M; Jenssen SE; Schwefel K; Spiegler S; Kleimeier D; Sperling C; Kaderali L; Felbor U
Eur J Med Genet; 2017 Sep; 60(9):479-484. PubMed ID: 28645800
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations within KRIT1/CCM1, MGC4607/CCM2 and PDCD10/CCM3 in a large Italian family harbouring a Krit1/CCM1 mutation.
Pileggi S; Buscone S; Ricci C; Patrosso MC; Marocchi A; Brunori P; Battistini S; Penco S
J Mol Neurosci; 2010 Oct; 42(2):235-42. PubMed ID: 20419355
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
[TBL] [Abstract][Full Text] [Related]
16. The cerebral cavernous malformations proteins.
Li X; Fisher OS; Boggon TJ
Oncotarget; 2015 Oct; 6(32):32279-80. PubMed ID: 26356566
[No Abstract] [Full Text] [Related]
17. Identification of a c.601C>G mutation in the CCM1 gene in a kindred with multiple skin, spinal and cerebral cavernous malformations.
Haghighi A; Fathi D; Shahbazi M; Motahari MM; Friedman B
J Neurol Sci; 2013 Nov; 334(1-2):97-101. PubMed ID: 24007869
[TBL] [Abstract][Full Text] [Related]
18. A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.
Nardella G; Visci G; Guarnieri V; Castellana S; Biagini T; Bisceglia L; Palumbo O; Trivisano M; Vaira C; Scerrati M; Debrasi D; D'Angelo V; Carella M; Merla G; Mazza T; Castori M; D'Agruma L; Fusco C
Hum Mutat; 2018 Dec; 39(12):1885-1900. PubMed ID: 30161288
[TBL] [Abstract][Full Text] [Related]
19. Defective autophagy is a key feature of cerebral cavernous malformations.
Marchi S; Corricelli M; Trapani E; Bravi L; Pittaro A; Delle Monache S; Ferroni L; Patergnani S; Missiroli S; Goitre L; Trabalzini L; Rimessi A; Giorgi C; Zavan B; Cassoni P; Dejana E; Retta SF; Pinton P
EMBO Mol Med; 2015 Nov; 7(11):1403-17. PubMed ID: 26417067
[TBL] [Abstract][Full Text] [Related]
20. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
